BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18459036)

  • 21. MRP2 mediated drug-drug interaction: indomethacin increases sulfasalazine absorption in the small intestine, potentially decreasing its colonic targeting.
    Dahan A; Amidon GL
    Int J Pharm; 2010 Feb; 386(1-2):216-20. PubMed ID: 19944137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP.
    Xiao L; Yi T; Chen M; Lam CW; Zhou H
    Eur J Pharm Sci; 2016 Oct; 93():456-67. PubMed ID: 27586020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CYP1A1 induction and CYP3A4 inhibition by the fungicide imazalil in the human intestinal Caco-2 cells-comparison with other conazole pesticides.
    Sergent T; Dupont I; Jassogne C; Ribonnet L; van der Heiden E; Scippo ML; Muller M; McAlister D; Pussemier L; Larondelle Y; Schneider YJ
    Toxicol Lett; 2009 Feb; 184(3):159-68. PubMed ID: 19070657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of efflux transporters on the transport of highly toxic aconitine, mesaconitine, hypaconitine, and their hydrolysates, as determined in cultured Caco-2 and transfected MDCKII cells.
    Ye L; Yang X; Yang Z; Gao S; Yin T; Liu W; Wang F; Hu M; Liu Z
    Toxicol Lett; 2013 Feb; 216(2-3):86-99. PubMed ID: 23200901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Piperine enhances the bioavailability of silybin via inhibition of efflux transporters BCRP and MRP2.
    Bi X; Yuan Z; Qu B; Zhou H; Liu Z; Xie Y
    Phytomedicine; 2019 Feb; 54():98-108. PubMed ID: 30668388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P-glycoprotein and breast cancer resistance protein affect disposition of tandutinib, a tyrosine kinase inhibitor.
    Yang JJ; Milton MN; Yu S; Liao M; Liu N; Wu JT; Gan L; Balani SK; Lee FW; Prakash S; Xia CQ
    Drug Metab Lett; 2010 Dec; 4(4):201-12. PubMed ID: 20670210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of efflux transport of the PDE5 inhibitors, vardenafil and sildenafil.
    Choi MK; Song IS
    J Pharm Pharmacol; 2012 Aug; 64(8):1074-83. PubMed ID: 22775210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zinc finger nuclease-mediated gene knockout results in loss of transport activity for P-glycoprotein, BCRP, and MRP2 in Caco-2 cells.
    Sampson KE; Brinker A; Pratt J; Venkatraman N; Xiao Y; Blasberg J; Steiner T; Bourner M; Thompson DC
    Drug Metab Dispos; 2015 Feb; 43(2):199-207. PubMed ID: 25388687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular Metabolomics Identifies Efflux Transporter Inhibitors in a Routine Caco-2 Cell Permeability Assay-Biological Implications.
    Naseem A; Pal A; Gowan S; Asad Y; Donovan A; Temesszentandrási-Ambrus C; Kis E; Gaborik Z; Bhalay G; Raynaud F
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Determine the Disposition of Esculetin-7-O-Glucuronide and 4-Methylesculetin-7-O-Glucuronide.
    Li Y; Song W; Ou X; Luo G; Xie Y; Sun R; Wang Y; Qi X; Hu M; Liu Z; Zhu L
    Drug Metab Dispos; 2019 Mar; 47(3):203-214. PubMed ID: 30602435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a novel thermostable glucose-tolerant GH1 β-glucosidase from the hyperthermophile Ignisphaera aggregans and its application in the efficient production of baohuoside I from icariin and total epimedium flavonoids.
    Xie J; Xu H; Jiang J; Zhang N; Yang J; Zhao J; Wei M
    Bioorg Chem; 2020 Nov; 104():104296. PubMed ID: 32987308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the antiretroviral drug 2'-deoxy-2'-β-fluoro-4'-azidocytidine (FNC) on P-gp, MRP2 and BCRP expressions and functions.
    Liu Y; Wang Y; Peng Y; Liu B; Ma F; Jiang J; Wang Q; Chang J
    Pharmazie; 2018 Sep; 73(9):503-507. PubMed ID: 30223932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the intestinal absorption of morroniside from Cornus officinalis Sieb. et Zucc via a Caco-2 cell monolayer model.
    Xu R; Zhu H; Hu L; Yu B; Zhan X; Yuan Y; Zhou P
    PLoS One; 2020; 15(5):e0227844. PubMed ID: 32470043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms responsible for poor oral bioavailability of paeoniflorin: Role of intestinal disposition and interactions with sinomenine.
    Liu ZQ; Jiang ZH; Liu L; Hu M
    Pharm Res; 2006 Dec; 23(12):2768-80. PubMed ID: 17063398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of P-glycoprotein in the intestinal absorption of glabridin, an active flavonoid from the root of Glycyrrhiza glabra.
    Cao J; Chen X; Liang J; Yu XQ; Xu AL; Chan E; Wei D; Huang M; Wen JY; Yu XY; Li XT; Sheu FS; Zhou SF
    Drug Metab Dispos; 2007 Apr; 35(4):539-53. PubMed ID: 17220245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium.
    Swed A; Eyal S; Madar I; Zohar-Kontante H; Weiss L; Hoffman A
    Mol Pharm; 2009; 6(6):1883-90. PubMed ID: 19722701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Affect regularity of medicinal species and heating time on flavonoids contents in Epimedium cut crude drug].
    Sun E; Chen LL; Jia XB; Qian Q; Cui L
    Zhong Yao Cai; 2012 Sep; 35(9):1402-7. PubMed ID: 23451493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model.
    Liu Y; Hu M
    Drug Metab Dispos; 2002 Apr; 30(4):370-7. PubMed ID: 11901089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of epimedium fried with suet oil based on in vivo formation of self-assembled flavonoid compound nanomicelles.
    Cui L; Sun E; Zhang ZH; Tan XB; Wei YJ; Jin X; Jia XB
    Molecules; 2012 Nov; 17(11):12984-96. PubMed ID: 23117437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical pharmacokinetics of PDE-310, a novel PDE4 inhibitor.
    Song JS; Rho HJ; Park JS; Kim MS; Lee BH; Seo JW; Jeon DJ; Cheon HG; Ahn SH; Kwon KI; Bae MA
    Drug Metab Pharmacokinet; 2011; 26(2):192-200. PubMed ID: 21206135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.